City Therapeutics vs Epicrispr Biotechnologies

City Therapeutics vs Epicrispr Biotechnologies, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: City Therapeutics is on 48/100 and Epicrispr Biotechnologies on 62/100.

City TherapeuticsA biopharmaceutical company developing RNA interference (RNAi)-based medicines.
Try City Therapeutics
Epicrispr Biotechnologies logo
Epicrispr BiotechnologiesEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Try Epicrispr Biotechnologies

Where each one leads

City Therapeutics

Leads on none of the measures we hold for both companies.

Epicrispr Biotechnologies

  • our overall score: 62/100 against 48/100
  • domain rating: 40/100 against 0/100

At a glance

MeasureCity TherapeuticsEpicrispr Biotechnologies
What it isA biopharmaceutical company developing RNA interference (RNAi)-based medicines.Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
CategoryBiotechnology, Pharmaceuticals, HealthTech, BiotechBiotechnology, Therapeutics, Rare Diseases, Epigenetics
Sells toBusiness modelB2BB2B
OfferingPlatformPlatform
Founded20192020
HeadquartersCambridge, USASouth San Francisco, United States
StatusActiveActive

Size, funding and growth

MeasureCity TherapeuticsEpicrispr Biotechnologies
EmployeesNot published51
Total funding$99.5M$90.0M
Latest roundSeries BSeries C
LinkedIn followersNot published7,025

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCity TherapeuticsEpicrispr Biotechnologies
StartupHub scoreOur 0-100 rating48/10062/100
Traction40/10057/100
TeamNot published40/100
Search visibility14/10020/100
Quality68/10078/100
Agent readinessHow well an AI agent can read and act on the siteD (41/100)F (39/100)
Domain ratingLink authority, 0-1000/10040/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCity TherapeuticsEpicrispr Biotechnologies
CDNCloudflareCloudflare
CMSNot detectedWordPress
FrameworksNot detectedJquery, Tailwind CSS, Bootstrap
AnalyticsNot detectedGoogle Analytics 4

What users say

MeasureCity TherapeuticsEpicrispr Biotechnologies
Reddit sentimentThreads we track4 positive, 0 negative across 4 threadsNot published
City Therapeutics
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics.
r/biotech

City Therapeutics vs Epicrispr Biotechnologies: common questions

Which is better, City Therapeutics or Epicrispr Biotechnologies?

On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do City Therapeutics and Epicrispr Biotechnologies compare on the numbers?

Epicrispr Biotechnologies leads on our overall score (62/100 against 48/100), domain rating (40/100 against 0/100).

What do real users say about City Therapeutics and Epicrispr Biotechnologies?

City Therapeutics: 4 positive and 0 negative mentions across 4 Reddit threads we track, mostly in r/biotech.

Read the full City Therapeutics review and pricing or the Epicrispr Biotechnologies review and pricing. You can also browse other City Therapeutics alternatives we track.